Thalassemia in Pakistan.

Area of Science:

• Public Health
• Genetics
• Healthcare Systems

Background:

• Pakistan's population exceeds 225 million, with a complex, dual federal and provincial healthcare system.
• The prevalence of beta-thalassemia (β-thal) trait in Pakistan is high, estimated at 5.0-7.0%, translating to over 10 million carriers.
• Approximately 5000 children are diagnosed with beta-thalassemia major (β-TM) annually, facing significant challenges due to lack of standard management protocols.

Purpose of the Study:

• To highlight the critical public health issue of beta-thalassemia (β-thal) in Pakistan.
• To underscore the absence of national prevention strategies and the challenges in implementing provincial initiatives.
• To address the socioeconomic barriers affecting the management and treatment of β-thalassemia major (β-TM).

Main Methods:

• Analysis of existing data on β-thalassemia (β-thal) carrier frequency and β-thalassemia major (β-TM) incidence in Pakistan.
• Review of the current healthcare delivery system structure at federal and provincial levels.
• Assessment of socioeconomic factors impacting patient access to care and treatment affordability.

Main Results:

• Over 10 million individuals carry the β-thalassemia (β-thal) trait, with ~5000 new β-thalassemia major (β-TM) cases annually.
• Blood transfusion is the primary management strategy due to the lack of standardized protocols.
• Provincial legislation for premarital screening exists in Sindh, Khyber Pakhtunkhwa (KPK), and Baluchistan, but faces implementation hurdles.

Conclusions:

• Pakistan requires urgent development and implementation of a national thalassemia prevention program.
• Addressing socioeconomic disparities is crucial for effective management of β-thalassemia major (β-TM).
• Successful implementation of provincial screening programs is essential to reduce the burden of β-thalassemia (β-thal).